- Home
- SEPN vs PRAA Comparison
SEPN vs PRAA Comparison
Compare SEPN & PRAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEPN
- PRAA
- Stock Information
- Founded
- SEPN 2022
- PRAA 1996
- Country
- SEPN United States
- PRAA United States
- Employees
- SEPN N/A
- PRAA N/A
- Industry
- SEPN
- PRAA Finance: Consumer Services
- Sector
- SEPN
- PRAA Finance
- Exchange
- SEPN NYSE
- PRAA Nasdaq
- Market Cap
- SEPN 453.2M
- PRAA 619.5M
- IPO Year
- SEPN 2024
- PRAA N/A
- Fundamental
- Price
- SEPN $11.76
- PRAA $15.79
- Analyst Decision
- SEPN Strong Buy
- PRAA Strong Buy
- Analyst Count
- SEPN 5
- PRAA 2
- Target Price
- SEPN $26.75
- PRAA $27.00
- AVG Volume (30 Days)
- SEPN 443.6K
- PRAA 457.5K
- Earning Date
- SEPN 08-15-2025
- PRAA 08-04-2025
- Dividend Yield
- SEPN N/A
- PRAA N/A
- EPS Growth
- SEPN N/A
- PRAA N/A
- EPS
- SEPN N/A
- PRAA 1.79
- Revenue
- SEPN $977,000.00
- PRAA $1,128,557,000.00
- Revenue This Year
- SEPN N/A
- PRAA $2.73
- Revenue Next Year
- SEPN $526.96
- PRAA $7.34
- P/E Ratio
- SEPN N/A
- PRAA $8.89
- Revenue Growth
- SEPN 108.76
- PRAA 25.02
- 52 Week Low
- SEPN $4.17
- PRAA $12.91
- 52 Week High
- SEPN $28.99
- PRAA $27.54
- Technical
- Relative Strength Index (RSI)
- SEPN N/A
- PRAA 56.18
- Support Level
- SEPN N/A
- PRAA $15.25
- Resistance Level
- SEPN N/A
- PRAA $16.41
- Average True Range (ATR)
- SEPN 0.00
- PRAA 0.62
- MACD
- SEPN 0.00
- PRAA 0.14
- Stochastic Oscillator
- SEPN 0.00
- PRAA 71.43
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
About PRAA PRA Group Inc.
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.